CONSOLIDATED BALANCE SHEET (USD $) In Millions, unless otherwise specified	Dec. 31, 2012		Dec. 31, 2011
Assets
Cash	$ 197		$ 215
Interest bearing deposits with banks	1,371		1,140
Securities purchased under agreements to resell	2,160		920
Securities available-for-sale	80		188
Receivables, net (including $4.9 billion and $5.3 billion at December 30, 2012 and 2011, respectively, collateralizing long-term debt)	29,284		43,201
Receivables held for sale	6,203	[1]	0	[1]
Properties and equipment, net	71		77
Real estate owned	227		299
Deferred income taxes, net	3,889		3,314
Other assets	1,264		1,312
Assets of discontinued operations	2,032		12,901
Total assets	46,778		63,567
Debt:
Due to affiliates (including $514 million and $447 million at December 31, 2012 and 2011, respectively, carried at fair value)	9,089		8,262
Commercial paper	0		4,026
Long-term debt (including $9.7 billion and $13.7 billion at December 31, 2012 and 2011, respectively, carried at fair value and $2.9 billion and $3.3 billion at December 31, 2012 and 2011, respectively, collateralized by receivables)	28,426		39,790
Total debt	37,515		52,078
Derivative related liabilities	22		26
Liability for postretirement benefits	263		280
Other liabilities	1,372		1,688
Liabilities of discontinued operations	1,501		2,569
Total liabilities	40,673		56,641
Common shareholder's equity:
Common stock ($0.01 par value, 100 shares authorized; 68 shares issued at both December 31, 2012 and 2011, respectively)	0		0
Additional paid-in capital	23,974		23,966
Accumulated deficit	(19,187)		(18,219)
Accumulated other comprehensive loss	(257)		(396)
Total common shareholder's equity	4,530		5,351
Total shareholders' equity	6,105		6,926
Total liabilities and shareholders' equity	46,778		63,567
Series B (1,501,100 shares authorized, $0.01 par value, 575,000 shares issued and outstanding)
Redeemable preferred stock:
Redeemable preferred stock value	575		575
Series C (1,000 shares authorized, $0.01 par value, 1,000 shares issued and outstanding)
Redeemable preferred stock:
Redeemable preferred stock value	$ 1,000		$ 1,000

[1] Net of a valuation allowance of $1.5 billion at December 31, 2012